Do  ||| S:0 E:3 ||| VB
selective  ||| S:3 E:13 ||| JJ
serotonin  ||| S:13 E:23 ||| FW
receptor  ||| S:23 E:32 ||| FW
inhibitor  ||| S:32 E:42 ||| FW
antidepressants  ||| S:42 E:58 ||| FW
reduce  ||| S:58 E:65 ||| FW
tamoxifen ||| S:65 E:74 ||| FW
's  ||| S:74 E:77 ||| POS
effectiveness  ||| S:77 E:91 ||| NN
and  ||| S:91 E:95 ||| CC
increase  ||| S:95 E:104 ||| VB
the  ||| S:104 E:108 ||| DT
risk  ||| S:108 E:113 ||| NN
of  ||| S:113 E:116 ||| IN
death  ||| S:116 E:122 ||| NN
from  ||| S:122 E:127 ||| IN
breast  ||| S:127 E:134 ||| JJ
cancer ||| S:134 E:140 ||| NN
?  ||| S:140 E:143 ||| .
